Silver Book Fact

Longitudinal study on vision loss in Medicare patients

A longitudinal study that followed Medicare patients found that after 9 years, almost 50% of survivors had developed glaucoma, cataract, or macular degeneration.

Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal Prevalence of Major Eye Diseases. Archives of Ophthalmology. 2003; 121(9): 1303-10. http://archopht.ama-assn.org/cgi/content/abstract/121/9/1303?etoc

Reference

Title
Longitudinal Prevalence of Major Eye Diseases
Publication
Archives of Ophthalmology
Publication Date
2003
Authors
Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA
Volume & Issue
Volume 121, Issue 9
Pages
1303-10
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor
  • Human Burden

Related Facts

  • Estimated Specific Prevalence Rates for Open-Angle Glaucoma  
  • People Affected Worldwide by DR
    By 2030, more than 191 million people around the world will be affected by DR—56 million with vision-threatening DR.  
  • A study of Medicare beneficiaries with glaucoma showed that health care costs increased with degree of vision loss–ranging from $8,157 per year for no vision loss to $18,670 for blindness.  
  • Estimated Cost of Reduced Labor Force Participation by People Who are Visually Impaired or Blind  
  • The number of Medicare beneficiaries newly diagnosed with wet age-related macular degeneratino (AMD) more than doubled between 1994 and 2006.